NewsRoom Articles - Page 95 of 226

MondayFeb 06, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Aiming to Capture Significant Market Share for Treatment and Prevention of COVID-19 Illness with Innovative Inhaled NanoAb

BiondVax is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products The company is developing nanosized antibodies (“NanoAbs”) addressing large market diseases underserved by current treatments, with its lead candidate targeting COVID-19 The FDA recently revoked the sole authorization of a COVID prophylactic, Evusheld, citing the inability of the monoclonal antibody cocktail to neutralize emerging subvariants of the Omicron variant BiondVax’s lead NanoAb candidate shows superior advantages to monoclonal antibodies, with the data gathered strengthening the value proposition of the COVID-19 NanoAb as a safe, efficacious, and convenient therapeutic and prophylactic drug The Food and Drug Administration…

FridayFeb 03, 2023 10:53 am

Global Clinical Guidelines to Prevent, Manage Cardiac Complications Among Pediatric Cancer Patients Published

Researchers from the Murdoch Children’s Research Institute in Melbourne have recently published the first-ever clinical guidelines to help prevent and address cardiac complications in pediatric cancer patients who are currently undergoing treatment. A growing body of research has revealed in recent years that pediatric cancer patients face a significant risk of developing additional medical complications later in life. Some of the treatments used to address tumors, such as radiation therapy, can be quite damaging to healthy cells. Even grown adults suffer side effects such as anemia, appetite loss, fatigue, bruising, bleeding, and hair loss. For children, these treatments can disrupt…

ThursdayFeb 02, 2023 12:21 pm

How Emotional Support, Service Dogs Differ

Although emotional support and service dogs may seem similar to the uninformed viewer, there are several critical differences between these two types of dogs. Dogs have been man's best friend for thousands of years, sticking with humans since the early days of cave painting and stone tools, through the middle ages, the industrial revolution and into the modern age. Dogs helped to protect human settlements from dangerous animals and other people; they were also instrumental in guarding and herding livestock for thousands of years. While plenty of dogs around the world still serve this function, most people use dogs for…

ThursdayFeb 02, 2023 9:00 am

MetAlert, Inc. (MLRT) Patient Tracking Technology To Gain User Access in Sweden’s Cognitive Care Centers

GPS-enabled location device developer MetAlert provides geographical tracking technology that is discrete and functional through shoe inserts that provide data connectivity to cognitive patient caregivers MetAlert announced in January that it is expanding the reach of its SmartSole flagship product through an agreement with Sweden’s government that was established by distribution partner Posifon AB Government agencies across Europe and in the United States have recognized the importance of being able to monitor the whereabouts of patients with cognitive concerns MetAlert’s development team has improved the SmartSole with a battery capable of lasting up to five days, and the company plans…

WednesdayFeb 01, 2023 11:50 am

Developing Heart Disease Earlier in Life Increases Cognitive Decline Later in Life

Heart disease is one of the most prolific killers in America, taking one life every 34 seconds and affecting nearly one-half of the country’s population. According to a new study from the University of California, San Francisco, people who develop heart disease earlier in their lives have an increased risk of experiencing cognitive decline later in life. The study found that people who suffer strokes or heart attacks in middle age may have problems with thinking and memory when they grow older. More specifically, the study focused on individuals who developed heart disease or leg artery disease, or who suffered…

TuesdayJan 31, 2023 12:14 pm

Research Links Two Natural Deposits to Onset of Macular Degeneration

Macular degeneration is an eye disorder that commonly affects people aged 50 years and older. It occurs when the inner layers of the macula, a region of the retina that provides the eye with a clear vision in the direct line of sight, begin to break down and function less effectively. Although we don’t know precisely what causes macular degeneration, research indicates that it may be due to a combination of environmental factors, including diet and obesity coupled with family genes and age. Close to 20 million Americans aged 40 and older are currently living with some kind of age-related…

MondayJan 30, 2023 11:15 am

MetAlert, Inc. (MLRT) Market for Self-actualized Wellness Grows

Wearable wellness technology innovator MetAlert is revitalizing its brand and increasing its product and services portfolio through M&A and other corporate developments designed to improve the company’s healthcare profile The mortality associated with chronic disease can be ameliorated with the use of wearable devices, along with other healthful practices, and the use of wearable wellness technology is expected to continue at an increasing pace More than 41 million people die of noncommunicable diseases (aka chronic illnesses) each year — 17 million of them before the age of 70, according to the World Health Organization MetAlert’s growing product slate is designed…

MondayJan 30, 2023 11:06 am

Study Determines That How Proteins Move May Influence Brain Tumor Growth

Proteins come in various shapes, making it hard to determine how they move and, in turn, how they function. A study conducted by researchers at the Karolinska Institute has discovered a new target for brain tumors through the use of computer simulations. Laura Orellana, a biophysicist at the institution’s Department of Oncology-Pathology, led the study, which looked into how proteins moved. The study used data from the Protein Data Bank, which comprises decades of information on the 3D structures of different kinds of biological molecules, including proteins. This data is based on experimental techniques such as nuclear magnetic resonance (NMR)…

MondayJan 30, 2023 10:30 am

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Reports Promising Prophylactic Results from Preclinical Proof-of-Concept NanoAb COVID-19 Study

BiondVax’s preclinical proof-of-concept study was designed to mimic a real-world situation regarding at-risk groups, including the elderly, people with comorbidities, the immunocompromised, travelers, those attending densely packed social events, and front-line healthcare workers The study shows promising prophylactic results with hamsters receiving BiondVax’s inhaled NanoAb three hours before infection experiencing no significant weight loss over the six-day trial; follows previously reported data showing successful use of NanoAb as COVID-19 therapeutic First-in-human Phase 1/2a clinical trial is planned for later this year Focused on the development, manufacture, and commercialization of innovative NanoAb immunotherapeutic products, BiondVax Pharmaceuticals (NASDAQ: BVXV) recently announced additional…

FridayJan 27, 2023 10:11 am

Study Finds Mucus-Eating Gut Bacteria May Cause Fever Following Cancer Treatment

Cancer treatments often take a huge toll on the patient’s body, causing adverse side effects such as blood clots, nausea and vomiting, hair loss, lymphedema and neutropenia. Neutropenia refers to the loss of neutrophils, which are a type of white blood cell. In severe neutropenia cases, patients develop a fever. New research has linked this fever to bacteria in the gut known as Akkermansia muciniphila (A. muciniphila). The study was led by a team of researchers at the University of Texas MD Anderson Cancer Center. It involved analyzing fecal samples collected from 119 patients who were undergoing stem cell transplantation.…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Aiming to Capture Significant Market Share for Treatment and Prevention of COVID-19 Illness with Innovative Inhaled NanoAb

Global Clinical Guidelines to Prevent, Manage Cardiac Complications Among Pediatric Cancer Patients Published

How Emotional Support, Service Dogs Differ

MetAlert, Inc. (MLRT) Patient Tracking Technology To Gain User Access in Sweden’s Cognitive Care Centers

Developing Heart Disease Earlier in Life Increases Cognitive Decline Later in Life

Research Links Two Natural Deposits to Onset of Macular Degeneration

MetAlert, Inc. (MLRT) Market for Self-actualized Wellness Grows

Study Determines That How Proteins Move May Influence Brain Tumor Growth

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Reports Promising Prophylactic Results from Preclinical Proof-of-Concept NanoAb COVID-19 Study

Study Finds Mucus-Eating Gut Bacteria May Cause Fever Following Cancer Treatment

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search